These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
320 related articles for article (PubMed ID: 36499289)
1. miRNA Pathway Alteration in Response to Non-Coding RNA Delivery in Viral Vector-Based Gene Therapy. Savenkova DA; Makarova AA; Shalik IK; Yudkin DV Int J Mol Sci; 2022 Nov; 23(23):. PubMed ID: 36499289 [TBL] [Abstract][Full Text] [Related]
2. [Development of a novel adenovirus vector exhibiting microRNA-mediated suppression of the leaky expression of adenovirus genes]. Shimizu K; Sakurai F; Tachibana M; Mizuguchi H Yakugaku Zasshi; 2012; 132(12):1407-12. PubMed ID: 23208048 [TBL] [Abstract][Full Text] [Related]
3. Viral vectors for gene delivery and gene therapy within the endocrine system. Stone D; David A; Bolognani F; Lowenstein PR; Castro MG J Endocrinol; 2000 Feb; 164(2):103-18. PubMed ID: 10657846 [TBL] [Abstract][Full Text] [Related]
4. Improving miRNA Delivery by Optimizing miRNA Expression Cassettes in Diverse Virus Vectors. Herrera-Carrillo E; Liu YP; Berkhout B Hum Gene Ther Methods; 2017 Aug; 28(4):177-190. PubMed ID: 28712309 [TBL] [Abstract][Full Text] [Related]
5. Viral-mediated gene transfer for cancer treatment. Wilson DR Curr Pharm Biotechnol; 2002 Jun; 3(2):151-64. PubMed ID: 12022258 [TBL] [Abstract][Full Text] [Related]
6. Immune responses to adenovirus and adeno-associated vectors used for gene therapy of brain diseases: the role of immunological synapses in understanding the cell biology of neuroimmune interactions. Lowenstein PR; Mandel RJ; Xiong WD; Kroeger K; Castro MG Curr Gene Ther; 2007 Oct; 7(5):347-60. PubMed ID: 17979681 [TBL] [Abstract][Full Text] [Related]
7. miRNA cassettes in viral vectors: problems and solutions. Liu YP; Berkhout B Biochim Biophys Acta; 2011; 1809(11-12):732-45. PubMed ID: 21679781 [TBL] [Abstract][Full Text] [Related]
8. Viral vectors for gene delivery to the central nervous system. Lentz TB; Gray SJ; Samulski RJ Neurobiol Dis; 2012 Nov; 48(2):179-88. PubMed ID: 22001604 [TBL] [Abstract][Full Text] [Related]
10. Strategies and methods for the detection and identification of viral vectors. Stellberger T; Koehler N; Dinkelmeier A; Draxler J; Haase M; Hellinckx J; Pavlovic M; Busch U; Baiker A Virus Genes; 2017 Oct; 53(5):749-757. PubMed ID: 28725978 [TBL] [Abstract][Full Text] [Related]
11. Invasive drug delivery. Blömer U; Ganser A; Scherr M Adv Exp Med Biol; 2002; 513():431-51. PubMed ID: 12575831 [TBL] [Abstract][Full Text] [Related]
12. A Review of Gene Therapy Delivery Systems for Intervertebral Disc Degeneration. Chen S; Luo M; Kou H; Shang G; Ji Y; Liu H Curr Pharm Biotechnol; 2020; 21(3):194-205. PubMed ID: 31749423 [TBL] [Abstract][Full Text] [Related]
13. Optimal delivery of RNA interference by viral vectors for cancer therapy. Wong B; Birtch R; Rezaei R; Jamieson T; Crupi MJF; Diallo JS; Ilkow CS Mol Ther; 2023 Nov; 31(11):3127-3145. PubMed ID: 37735876 [TBL] [Abstract][Full Text] [Related]
14. Virus vector design in gene therapy. Günzburg WH; Salmons B Mol Med Today; 1995 Dec; 1(9):410-7. PubMed ID: 9415189 [TBL] [Abstract][Full Text] [Related]
15. Advances in the development of non-human viral DNA-vectors for gene delivery. Löser P; Hüser A; Hillgenberg M; Kümin D; Both GW; Hofmann C Curr Gene Ther; 2002 May; 2(2):161-71. PubMed ID: 12109213 [TBL] [Abstract][Full Text] [Related]